Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The other side of Suboxone

Dennis Wichern
Meds
July 28, 2018
Share
Tweet
Share

A lot has been written about Suboxone, the buprenorphine treatment drug. For many, Suboxone acts as an effective medication to treat opioid addiction. For others, it’s a highly-valued street drug that is commonly diverted and misused. To understand and acknowledge the darker side of Suboxone we have to look back at its history over the past 16 years.

History of Suboxone

Suboxone was first approved by the FDA in 2002 to treat opioid addiction in office-based opioid treatment programs. Prior to Suboxone, the only opioid treatment drug available was methadone, which could only be obtained from an opioid treatment program or methadone clinic. Suboxone was initially manufactured in tablet form but was subsequently changed to a dissolvable oral filmstrip in 2010.

Currently, over 35 states have filed lawsuits against the drug’s manufacturer alleging antitrust violations regarding the tablet to film reformulation.

Prison heroin

Suboxone smuggling into correctional institutions is a significant issue across the nation with the drug oftentimes hidden in books and letters because of its filmstrip form. The New York Times in 2011 was the first to report that law enforcement was witnessing the abuse of Suboxone inside prisons from Maine to New York.

In a subsequent 2013 Times article, Suboxone was referred to as “medication and dope” and “a treatment with considerable successes and also failures, as well as a street and prison drug bedeviling local authorities.” The same article dubbed the drug “prison heroin” because inmates were using it to get high, instead of its intended helpful use.

Unfortunately, the smuggling of Suboxone into jails and prisons continues to this day but several states have taken action.
On July 1, 2016, Maryland’s Medicaid program stopped allowing Suboxone strips in an effort to stop the illicit flow of the drug into jails and prisons. According to a NPR article, the amount of diversion was “staggering.” Zubslov, a tablet containing buprenorphine and naloxone was added to the program’s formulary as an alternative treatment drug.

And in April of 2017, the Wisconsin Sheriff’s Association asked the state’s medicaid director for assistance in reducing the smuggling of Suboxone into the jails of Wisconsin. As a result, Zubsolv was added to the formulary in the hope that the tablets become used more than the strips.

A new type of pill mill?

The emergence of Suboxone has also brought unscrupulous providers into the opioid treatment profession who operate cash-only prescription clinics with some calling this phenomenon, “the second coming of the old pill mills.”

The states of West Virginia, Kentucky and Tennessee have all recently implemented oversight regulations concerning treatment clinics in their states due to concerns about inadequate treatment and the rise of Suboxone “pill mills.” In Kentucky, one provider had his receptionist and maintenance man handing out Suboxone prescriptions when he was absent.

Why is this happening? Street value.

Suboxone is a valuable drug on the street and is used by those with an opioid use disorder to experience its euphoric effect, prevent opioid withdrawal, profit off its sales or to self-medicate.

A 2017 Dayton Daily News article detailed the street value of 60 Suboxone film strips rings up at $1,200 per month, and in a correctional facility, a strip of Suboxone is worth $100.

So, how big an issue is this?

ADVERTISEMENT

According to DEA statistics, there were 446 crime laboratory reports involving buprenorphine in 2005 which rose by over 4,000% to 18,077 in 2016, the most recent data set available.

Buprenorphine is now the fourth most encountered opioid drug analyzed by nationwide crime laboratories trailing only oxycodone, fentanyl, and hydrocodone.

A doctor in Tennessee found a 60% decrease of statewide prescriptions for Suboxone during 2016 when the state changed the Medicaid formulary to Bunavail, a lesser dose alternative to Suboxone.

And in 2017 the University of Kentucky published a study which found that out of 1,675 substance users, 985 reported taking Suboxone at some point, with only six percent receiving it by prescription, 62% by illegal means and 32% both ways. Nearly 80% of those who received it both illegally and by prescription admitted selling, trading or giving away what they were prescribed. More than 75% admitted mixing Suboxone with other drugs or alcohol to get high.

What should a MAT provider do to mitigate diversion while still helping those in need?

Follow a national guideline like SAMHSA’s TIP 40, SAMHSA’s TIP 63 or ASAM’s 2015 National Guidelines which include diversion plans that include weekly office visits until the patient is stable, urine drug testing including testing for buprenorphine, recall visits for pill counts and limiting the dose to decrease the risk of street sales. These same guidelines also emphasize the importance of psychosocial treatment in conjunction with medication-assisted treatment.

Suboxone and other buprenorphine medications are important tools in a treatment provider’s toolbox but prescribing only medication— without any other treatment support — is short-changing those in need.

As ASAM’s sample patient treatment agreement states, “I understand that treatment of opioid addiction involves more than just taking my medication. I agree to comply with my doctor’s recommendations for additional counseling and/or for help with other problems.”

Dennis Wichern is a retired DEA agent.

Image credit: Shutterstock.com

Prev

Technology ought to save lives. So why aren't we using it better?

July 28, 2018 Kevin 4
…
Next

What personality type fits your medical specialty?

July 29, 2018 Kevin 13
…

Tagged as: Pain Management, Psychiatry

Post navigation

< Previous Post
Technology ought to save lives. So why aren't we using it better?
Next Post >
What personality type fits your medical specialty?

ADVERTISEMENT

More by Dennis Wichern

  • CBD: What is it? A former DEA agent explains.

    Dennis Wichern
  • Telemedicine should be easy. Here’s why it’s not.

    Dennis Wichern
  • How to avoid negative press and fines during the opioid crisis

    Dennis Wichern

Related Posts

  • Suboxone for pain makes sense. Why don’t more doctors prescribe it?

    Hans Duvefelt, MD
  • Stop stigmatizing medication-assisted treatment

    Brandon Jacobi
  • A drug problem in rural Georgia

    Ashish Advani, PharmD
  • How hospitals can impact generic drug companies

    Mark Kelley, MD
  • Drug ads are a campaign against physician trust

    Judy Salz, MD
  • Crippling drug costs: the role of insurers

    Janice Boughton, MD

More in Meds

  • Every medication error is a system failure, not a personal flaw

    Muhammad Abdullah Khan
  • Why kratom addiction is the next public health crisis

    Muhamad Aly Rifai, MD
  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • Most Popular

  • Past Week

    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • When life makes you depend on Depends

      Francisco M. Torres, MD | Physician
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
    • How denial of hypertension endangers lives and what doctors can do

      Dr. Aminat O. Akintola | Conditions
    • A powerful story of addiction, strength, and redemption

      Ryan McCarthy, MD | Physician
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Why doctors should rethink investing compared to the average U.S. investor [PODCAST]

      The Podcast by KevinMD | Podcast
    • How chronic stress harms the heart in minority communities

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • The dying man who gave me flowers changed how I see care

      Augusta Uwah, MD | Physician
    • Universities must tap endowments to sustain biomedical research

      Adeel Khan, MD | Conditions
    • Exploring the science behind burnout [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 11 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • When life makes you depend on Depends

      Francisco M. Torres, MD | Physician
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
    • How denial of hypertension endangers lives and what doctors can do

      Dr. Aminat O. Akintola | Conditions
    • A powerful story of addiction, strength, and redemption

      Ryan McCarthy, MD | Physician
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Why doctors should rethink investing compared to the average U.S. investor [PODCAST]

      The Podcast by KevinMD | Podcast
    • How chronic stress harms the heart in minority communities

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • The dying man who gave me flowers changed how I see care

      Augusta Uwah, MD | Physician
    • Universities must tap endowments to sustain biomedical research

      Adeel Khan, MD | Conditions
    • Exploring the science behind burnout [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The other side of Suboxone
11 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...